Found: 25
Select item for more details and to access through your institution.
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E54, doi. 10.1002/ajh.24977
- By:
- Publication type:
- Article
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. E656, doi. 10.1002/ajh.24903
- By:
- Publication type:
- Article
Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. E123, doi. 10.1002/ajh.23990
- By:
- Publication type:
- Article
Tandem high?dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 2, p. 122, doi. 10.1002/ajh.20790
- By:
- Publication type:
- Article
Induzione di remissione completa molecolare indotta da un ciclo di CPX-351 in una paziente affetta da carcinoma ovarico e leucemia mieloide acuta therapy-related.
- Published in:
- Current Therapeutics, 2021, v. 24, n. 3, p. 9
- By:
- Publication type:
- Article
AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S307, doi. 10.1016/S2152-2650(21)01729-8
- By:
- Publication type:
- Article
Poster: AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01316-1
- By:
- Publication type:
- Article
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
- Published in:
- Transfusion, 2014, v. 54, n. 2, p. 331, doi. 10.1111/trf.12265
- By:
- Publication type:
- Article
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia.
- Published in:
- Cancer Reports, 2024, v. 7, n. 8, p. 1, doi. 10.1002/cnr2.2141
- By:
- Publication type:
- Article
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 369, doi. 10.1111/j.1365-2141.2009.07645.x
- By:
- Publication type:
- Article
Rituximab in thrombotic microangiopathy.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 4, p. 322, doi. 10.1111/j.1600-0609.2007.00814.x
- By:
- Publication type:
- Article
CD34<sup>+</sup> dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 2, p. 111, doi. 10.1111/j.1600-0609.2006.00793.x
- By:
- Publication type:
- Article
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 992, doi. 10.1002/cncr.34608
- By:
- Publication type:
- Article
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 440, doi. 10.1111/bjh.18537
- By:
- Publication type:
- Article
HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 2, p. 152, doi. 10.3390/biology10020152
- By:
- Publication type:
- Article
I VETERANI DI LEGIONE IN ITALIA IN ETÀ IMPERIALE. UN AGGIORNAMENTO.
- Published in:
- Thiasos, 2023, n. 12, p. 31
- By:
- Publication type:
- Article
Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro‐costing analysis in three Italian hematology centers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21480, doi. 10.1002/cam4.6699
- By:
- Publication type:
- Article
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 386, doi. 10.3390/cancers16020386
- By:
- Publication type:
- Article
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4623, doi. 10.3390/cancers15184623
- By:
- Publication type:
- Article
VARRO'S WRITINGS ON THE SENATE: A RECONSTRUCTIVE HYPOTHESIS.
- Published in:
- Bulletin of the Institute of Classical Studies, 2017, v. 60, n. 2, p. 49, doi. 10.1111/2041-5370.12056
- By:
- Publication type:
- Article
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 10, p. 1791, doi. 10.1002/ijc.34162
- By:
- Publication type:
- Article
Clinical presentation, diagnosis and management of therapy‐related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly‐ADP‐ribose polymerase inhibitors: A single‐center experience.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 1, p. 170, doi. 10.1002/ijc.33269
- By:
- Publication type:
- Article
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1099, doi. 10.1007/s00277-023-05162-0
- By:
- Publication type:
- Article
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367393
- By:
- Publication type:
- Article